Significance Psoriasis is an inflammatory skin disease affecting 2–3% of the population. IL-17A plays a key role in psoriasis pathogenesis, and antibodies targeting IL-17A have recently been approved for psoriasis treatment. Here we demonstrate that IκBζ is a key protein for IL-17A–driven effects…